欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/5268/003
药品名称Dabigatran CF 150 mg, harde capsules
活性成分
    • Dabigatran etexilate mesilate 150.0 mg
剂型Capsule, hard
上市许可持有人Centrafarm B.V. Nieuwe Donk 3 4879 AC, Etten-Leur The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Dabigatran CF 150 mg, harde capsules
互认成员国 - 产品名称
    • Luxembourg (LU)
    • Slovakia (SK)
    • Iceland (IS)
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Germany (DE)
    • Sweden (SE)
    • Denmark (DK)
    • Finland (FI)
    • Belgium (BE)
      Dabigatran etexilate Eurogenerics 150 mg harde capsules
    • Hungary (HU)
许可日期2023/10/03
最近更新日期2024/07/18
药物ATC编码
    • B01AE07 dabigatran etexilate
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase